The Scottish Medicines Consortium (SMC) have announced that sotatercept, the ‘first in class’ PAH treatment, will not be commissioned for use by NHS Scotland at this stage.
9 February 2026
The UK’s specialist PH service is the envy of the world, and the latest National Audit of Pulmonary Hypertension has once again confirmed that it delivers high standards of care for patients.
19 January 2026
The beautiful Chelsea Physic Garden in London was the setting for another inspiring PH Research Forum last month, and it was our pleasure to support it once again.
8 December 2025
Study findings, released on PH Day UK, offer a unique perspective on the patient-defined symptom burden of pulmonary hypertension.
7 November 2025
Following the tightening of the government eligibility criteria, having a PH diagnosis doesn't automatically qualify someone to receive the vaccine this year.
14 October 2025This real-world study aimed to discover which PH symptoms affect people most and how lives are impacted. While patients in the UK have access to some of the world’s leading treatments, many still face significant challenges in their daily lives. The research aimed to uncover the specific nature of these difficulties and provide a deeper […]
14 October 2025
